Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Immunol ; 181(5): 3495-502, 2008 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-18714022

RESUMEN

Platelets express TLR4 receptors, but its ligand LPS does not directly activate thrombotic functions nor, obviously, transcription by these anucleate cells. Platelets, however, store information that changes their phenotype over a few hours in the form of unprocessed RNA transcripts. We show even low concentrations of LPS in the presence of soluble CD14 initiated splicing of unprocessed IL-1beta RNA, with translation and accumulation of IL-1beta protein. LPS was a more robust agonist for this response than thrombin. Platelets also contained cyclooxygenase-2 pre-mRNA, which also was spliced and translated after LPS stimulation. Flow cytometry and immunocytochemistry of platelets extensively purified by negative immunodepletion showed platelets contained IL-1beta, and quantitative assessment of white blood cell contamination by CD14 real time PCR confirms that leukocytes were not the IL-1beta source, nor were they required for platelet stimulation. LPS did not initiate rapid platelet responses, but over time did prime platelet aggregation to soluble agonists, induced actin rearrangement, and initiated granule secretion with P-selectin expression that resulted the coating of quiescent leukocytes with activated platelets. LPS is a direct agonist for platelets that allows these cells to directly participate in the innate immune response to bacteria.


Asunto(s)
Plaquetas/efectos de los fármacos , Ciclooxigenasa 2/genética , Interleucina-1beta/genética , Lipopolisacáridos/farmacología , Empalme del ARN/efectos de los fármacos , Plaquetas/metabolismo , Adhesión Celular , Células Cultivadas , Humanos , Interleucina-1beta/análisis , Leucocitos , Activación Plaquetaria , Agregación Plaquetaria , ARN Mensajero
2.
Cardiovasc Diabetol ; 5: 13, 2006 Jun 20.
Artículo en Inglés | MEDLINE | ID: mdl-16787541

RESUMEN

BACKGROUND: Foam cell formation in diabetic patients often occurs in the presence of high insulin and glucose levels. To test whether hyperinsulinemic hyperglycemic conditions affect foam cell differentiation, we examined gene expression, cytokine production, and Akt phosphorylation in human monocyte-derived macrophages incubated with two types of oxidized low density lipoprotein (LDL), minimally modified LDL (mmLDL) and extensively oxidized LDL (OxLDL). METHODS AND RESULTS: Using Affymetrix GeneChip arrays, we found that several genes directly related to insulin signaling were changed. The insulin receptor and glucose-6-phosphate dehydrogenase were upregulated by mmLDL and OxLDL, whereas insulin-induced gene 1 was significantly down-regulated. In hyperinsulinemic hyperglycemic conditions, modified LDL upregulated Akt phosphorylation and expression of the insulin-regulated aminopeptidase. The level of proinflammatory cytokines, IL-lbeta, IL-12, and IL-6, and of a 5-lipoxygenase eicosanoid, 5-hydroxyeicosatetraenoic acid (5-HETE), was also increased. CONCLUSION: These results suggest that the exposure of macrophages to modified low density lipoproteins in hyperglycemic hyperinsulinemic conditions affects insulin signaling and promotes the release of proinflammatory stimuli, such as cytokines and eicosanoids. These in turn may contribute to the development of insulin resistance.


Asunto(s)
Diferenciación Celular/fisiología , Células Espumosas/citología , Células Espumosas/metabolismo , Glucosa/metabolismo , Insulina/metabolismo , Macrófagos/citología , Macrófagos/metabolismo , Células Cultivadas , Colesterol/metabolismo , Citocinas/biosíntesis , Expresión Génica/efectos de los fármacos , Humanos , Ácidos Hidroxieicosatetraenoicos/biosíntesis , Lipoproteínas LDL/clasificación , Lipoproteínas LDL/farmacología , Macrófagos/efectos de los fármacos , Fosforilación , Proteínas Proto-Oncogénicas c-akt/metabolismo , Transducción de Señal/genética
3.
Int J Exp Diabetes Res ; 3(3): 163-9, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12458657

RESUMEN

Two classes of inositol phosphoglycans have been implicated as second messengers of insulin, one that activates pyruvate dehydrogenase and contains D-chiroinositol, and one that inhibits cyclic AMP-dependent protein kinase and contains myoinositol. We examined the effects of a 3-day fast on muscle contents of inositols in healthy humans. An oral glucose tolerance test was performed and a biopsy was obtained from the quadriceps femoris muscle after an overnight fast and after a 72-hour fast. The 72-hour fast significantly increased plasma glucose (1.5- to 2-fold) and insulin (2- to 4-fold) after glucose ingestion versus the values after the overnight fast, indicating the manifestation of peripheral insulin resistance. The 72-hour fast resulted in an approximately 20% decrease in the muscle content of D-chiroinositol (P < 0.02), but no change in the myoinositol content. These data demonstrate that fasting specifically decreases the muscle content of D-chiroinositol in human muscle and this may contribute to the finding that insulin-mediated activation of pyruvate dehydrogenase is attenuated after short-term starvation.


Asunto(s)
Ayuno/metabolismo , Inositol/metabolismo , Músculo Esquelético/metabolismo , Adulto , Femenino , Prueba de Tolerancia a la Glucosa , Humanos , Masculino , Valores de Referencia , Estereoisomerismo , Muslo , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA